How we got access to clinical study reports in 2011 despite EMA’s steadfast refusal
On 1 February 2011, we got access to the clinical study reports and their corresponding protocols of placebo controlled trials of two slimming pills, rimonabant and orlistat, submitted by the manufacturers to the European Medicines Agency (EMA) for obtaining marketing approval in the European Union. We applied for access in June 2007, but EMA did […]
How we got access to clinical study reports in 2011 despite EMA’s steadfast refusal Read More »